Cancer drug discovery biologists - in collaboration with Myricx Pharma Ltd
We are seeking outstanding molecular cell biologists at both research associate and research assistant level to lead and support a drug discovery and development team in the group of Professor Ed Tate, sponsored by Myricx Pharma Ltd, a drug discovery spinout founded by Imperial College and the Francis Crick Institute. The positions are available full time from January 2020 (or as soon as possible thereafter), for 12 months in the first instance with the potential for extension subject to progress.
We welcome informal enquiries from potential postdoctoral fellows with outstanding research track records who are prepared to apply for independent research funding, for example from the European Union, HFSP, etc. Full assistance will be given in preparing a competitive research proposal; we have an exceptional track record in accelerating the careers of outstanding postdoctoral researchers, with six Marie Curie fellows in our lab in the past four years.
Cross-institutional PhD studentship opportunity
A four year studenship is available from October 2020 as part of the The Institute of Cancer Research and Imperial College London's Convergence Science PhD Programme. The studentship will be supervised by Prof Ed Tate and Prof Louis Chester (ICR) studying a multidisciplinary approach to target MYC-driven childhood cancers. For full details see: https://www.icr.ac.uk/studying-and-training/phds-for-science-graduates/icr-imperial-convergence-science
Other PhD studentships
Any students interested in pursuing postgraduate research in our group should contact me directly; all prospective applicants should have or expect to obtain a 1st class honours degree (or equivalent) in chemistry, biochemistry, or a closely related discipline; non-UK students must be able to obtain independent funding for their studies, e.g. via a government bursary.